These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 4769664)
21. The immune response to vaccinia virus is significantly reduced after scarification with TK- recombinants as compared to wild-type virus. Phillpotts RJ; Lescott T; Gates AJ; Jones L Acta Virol; 2000; 44(3):151-6. PubMed ID: 11155357 [TBL] [Abstract][Full Text] [Related]
22. Preparation and immunological response to a new mixed vaccine composed of inactivated Newcastle disease virus, inactivated infectious bronchitis virus, and inactivated Hemophilus gallinarum. Otsuki K; Iritani Y Avian Dis; 1974 Jul; 18(3):297-304. PubMed ID: 4853743 [No Abstract] [Full Text] [Related]
23. [Maternal-fetal transfer of vaccine antibodies]. Stickl H; Noelke M Monatsschr Kinderheilkd (1902); 1970 Nov; 118(11):606-8. PubMed ID: 5531155 [No Abstract] [Full Text] [Related]
24. Clinical efficacy of intramuscular vaccinia immune globulin: a literature review. Hopkins RJ; Lane JM Clin Infect Dis; 2004 Sep; 39(6):819-26. PubMed ID: 15472814 [TBL] [Abstract][Full Text] [Related]
25. Serological response and virus shedding of chickens inoculated with reovirus via different routes. Mukiibi-Muka G; Jones RC; Kibenge FS Res Vet Sci; 1984 Sep; 37(2):227-9. PubMed ID: 6438745 [TBL] [Abstract][Full Text] [Related]
26. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. Manischewitz J; King LR; Bleckwenn NA; Shiloach J; Taffs R; Merchlinsky M; Eller N; Mikolajczyk MG; Clanton DJ; Monath T; Weltzin RA; Scott DE; Golding H J Infect Dis; 2003 Aug; 188(3):440-8. PubMed ID: 12870127 [TBL] [Abstract][Full Text] [Related]
27. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma. Gómez CE; Abaitua F; Rodríguez D; Esteban M Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077 [TBL] [Abstract][Full Text] [Related]
28. Immunologic responses to vaccinia vaccines administered by different parenteral routes. McClain DJ; Harrison S; Yeager CL; Cruz J; Ennis FA; Gibbs P; Wright MS; Summers PL; Arthur JD; Graham JA J Infect Dis; 1997 Apr; 175(4):756-63. PubMed ID: 9086127 [TBL] [Abstract][Full Text] [Related]
29. [An unusual infection with the vaccinia virus (poxvirus officinale)]. Kirsch WD; Handrick W; Keller HP Dtsch Med Wochenschr; 1973 Jun; 98(26):1292-4. PubMed ID: 4714029 [No Abstract] [Full Text] [Related]
30. Immune response of pigs to inactivated foot-and-mouth disease vaccines. Response to emulsion vaccines. Anderson EC; Masters RC; Mowat GN Res Vet Sci; 1971 Jul; 12(4):342-50. PubMed ID: 5558541 [No Abstract] [Full Text] [Related]
31. Serological response of chickens, rabbits and guinea-pigs to equine influenza vaccines. Frerichs GN; Frerichs CC Res Vet Sci; 1973 Mar; 14(2):187-93. PubMed ID: 4805140 [No Abstract] [Full Text] [Related]
32. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus. Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703 [TBL] [Abstract][Full Text] [Related]
33. Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers. Hopkins RJ; Kramer WG; Blackwelder WC; Ashtekar M; Hague L; Winker-La Roche SD; Berezuk G; Smith D; Leese PT Clin Infect Dis; 2004 Sep; 39(6):759-66. PubMed ID: 15472804 [TBL] [Abstract][Full Text] [Related]
34. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner. Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291 [TBL] [Abstract][Full Text] [Related]
35. Antibody in tears following intranasal vaccination with inactivated virus. 3. Role of tear and serum antibody in experimental vaccinia conjunctivitis. Knopf HL; Blacklow NR; Glassman MI; Cline WL; Wong VG Invest Ophthalmol; 1971 Oct; 10(10):760-9. PubMed ID: 4941860 [No Abstract] [Full Text] [Related]
36. The immune response of channel catfish. I. Basic responsiveness to soluble and viral antigens. McGlamery MH; Dawe DL; Gratzek JB Wildl Dis; 1971 Oct; 7(4):299-306. PubMed ID: 4330403 [No Abstract] [Full Text] [Related]
37. The significance of the challenge strain in the potency assay of the antivaccinia immunoglobulin preparation. Nyerges G; Csukás M; Láng Cs Dev Biol Stand; 1974; 27():98-101. PubMed ID: 4463129 [No Abstract] [Full Text] [Related]
39. Monitoring of human immunological responses to vaccinia virus. Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020 [TBL] [Abstract][Full Text] [Related]
40. The significance of the challenge strain in the potency assay of the anti-vaccinia immunoglobulin preparations. Nyerges G; Csukás M; Láng CS Ann Immunol Hung; 1973; 17():63-5. PubMed ID: 4805815 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]